Encompass Health Corporation (NYSE: EHC) reported Q2 EPS of $1.40, $0.19 better than the analyst estimate of $1.21. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Encompass Health Corporation sees FY2025 EPS of $5.12-$5.34, versus the consensus of $5.02. Encompass Health Corporation sees FY2025 revenue of $5.88-5.98 billion, versus the consensus of $5.89 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.